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Abstract
Background: Cytoplasmic viral double-stranded RNA (dsRNA) is detected by a class of ubiquitous cytoplasmic RNA
helicases, retinoic acid inducible gene-I (RIG-I) and melanoma differentiation antigen-5 (MDA5), which initiate a
signaling cascade via their common adaptor called interferon-b (IFN-b) promoter stimulator-1 (IPS-1). This leads to
the production of proinflammatory and antiviral cytokines, the type I Interferons, via mainly nuclear factor kappa B
(NF-B) and interferon response factor-3 (IRF3) transcription factors. Fas-associated death domain (FADD) protein,
receptor-interacting protein (RIP1), caspase-8 and tumor necrosis factor receptor (TNFR)-associated death domain
(TRADD) protein, all traditionally associated with death receptor signaling, are also involved in RIG-I/MDA5 signaling
pathway. We previously showed that FLIP (Flice-like inhibitory protein), also designated as cflar (CASP8 and FADD-
like apoptosis regulator), negatively regulates lipopolysaccharide (LPS)-induced toll-like receptor 4 (TLR4) signaling
in endothelial cells and mouse embryonic fibroblasts (MEFs) and protected against TLR4-mediated apoptosis.
Results: In this study, we investigated the role of FLIP in cellular response to cytoplasmic polyinosinic:polycytidylic
acid, poly(I:C), a synthetic analog of dsRNA. Consistent with the previously described role of FADD in RIG-I/MDA5-
mediated apoptosis, we found that FLIP
-/- MEFs were more susceptible to killing by cytoplasmic poly(I:C). However,
FLIP
-/- MEFs also exhibited markedly increased expression of NF-B-and IRF3- dependent genes in response to
cytoplasmic poly(I:C). Importantly, reconstitution of FLIP in FLIP
-/-MEFs reversed the hyper-activation of IRF3- and
NF-B-mediated gene expression. Further, we found that caspase-8 catalytic activity was not required for
cytoplasmic poly(I:C)-mediated NF-B and IRF3 signaling.
Conclusions: These results provide evidence for a crucial dual role for FLIP in antiviral responses to cytoplasmic
dsRNA: it protects from cytoplasmic dsRNA-mediated cell death while down-regulating IRF3-and NF-B-mediated
gene expression. Since the pathogenesis of several viral infections involves a heightened and dysregulated cytokine
response, a possible therapy could involve modulating FLIP levels.
Background
Cells respond to a viral challenge by rapidly producing
type I Interferons (IFNs). The type I IFNs, IFN-a and IFN-
b, are key cytokines, which induce an antiviral state and
facilitate innate and adaptive immune responses [1]. The
induction of IFN-b is regulated by several transcription
factors such as nuclear factor kappa (NF-B) and inter-
feron regulatory factor-3 (IRF3). IRF3 activation requires
phosphorylation by two kinases, TANK-binding kinase 1
(TBK1) and IB kinase (IKK)ε [2]. Activated NF-Ba n d
IRF3 translocate to the nucleus and trigger the expression
of Type I IFNs, which are then secreted and bind to their
cognate receptors on host cells. The mammalian Toll-like
receptors (TLRs) that recognize the viral nucleic acids are
TLR3, TLR7/8, and TLR9 for double-stranded RNA
(dsRNA), single-stranded RNA, and DNA, respectively [1].
In addition, dsRNA is sensed by a ubiquitous family of
cytoplasmic RNA helicases, retinoic acid-inducible gene-I
(RIG-I) and Melanoma differentiation-associated gene
(MDA-5) [3], jointly referred to as RIG-like helicases
(RLHs). While both serve as cytoplasmic sensors of RNA
and function through a common adaptor protein called
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MAVS, VISA, or Cardiff), a more precise picture of the
substrates that they recognize has emerged. While RIG-I
binds short double-stranded RNA with triphosphate or
monophosphate at the 5’ end, short lengths of poly(I:C)
and predominantly negative sense single stranded viral
RNAs [4,5]; MDA-5 binds long lengths of poly(I:C) and
mostly positive sense-single stranded viral RNA [5,6]. The
RLHs trigger the production of IFN-b in response to cyto-
plasmic dsRNA. The RLHs contain two caspase recruit-
ment domains (CARDs), which mediate the activation of
transcription factors like NF-B, IRF3, and IRF7. Further,
IPS-1 is also a CARD-containing downstream adaptor of
the RLHs. Interestingly, several cytoplasmic adaptors of
death receptor signaling have been shown to be involved
in RLH signaling. IPS-1 has been demonstrated to interact
with Fas-associated death domain (FADD), an adaptor in
Fas signaling, and receptor-interacting protein-1 (RIP1)
[7]. Also, caspase-8, the apical caspase activated by tumor
necrosis factor receptor (TNFR) and Fas, is cleaved in
response to dsRNA, and, when over-expressed, its death
effector domain (DED) can activate NF-B in response to
dsRNA [8]. Further, Michallet and coworkers reported
that TNFR-associated death domain (TRADD), the proxi-
mal adaptor in TNFR signaling pathway, plays a crucial
role in antiviral signaling by interacting with IPS-1 and
activating NF-B and IRF3 in response to RNA virus [9].
In view of the involvement of several death receptor
proteins in RLH signaling, we investigated the role of
FLIP, a key regulator of TNFR and Fas signaling in viral
responses. FLIP is homologous in structure to caspase-8,
but is catalytically inactive due to critical mutations in
the catalytic domain [10]. By binding to TRADD or
FADD and preventing caspase-8 recruitment, FLIP func-
tions as a potent inhibitor of TNFR and Fas apoptotic
signaling [11]. FLIP has also been shown to regulate
NF-B activation induced by Fas engagement [12]. Pre-
vious work from our laboratory also delineated a dual
role of FLIP in response to LPS signaling through TLR4.
FLIP protected against LPS-induced apoptosis and
down-regulated LPS-induced NF-B activation [13]. In
this study we find that FLIP not only protected from
apoptosis induced by cytoplasmic poly(I:C), a synthetic
analog of dsRNA, but also down-regulated poly(I:C)-
induced NF-B and IRF3-mediated type I IFN produc-
tion. Further, we find that while the caspase-8 catalytic
activity is important for poly(I:C)-induced death, it was
not required for IRF3-mediated gene expression.
Methods
Cells and reagents
Wild type MEFs, FLIP
-/+ heterozygous MEFs, and
FLIP
-/- MEFs were generous gifts of Wen-Chen Yeh,
Amgen Institute, Toronto, Canada. The MEFs were
cultured as described in DMEM (Hyclone) enriched
with 10% fetal bovine serum, glutamine (2 mmol/L),
sodium pyruvate (1 mmol/L), and non essential amino
acids, in the presence of penicillin (100 U/ml) and strep-
tomycin (100 μg/ml) [13]. In our studies, wild type
MEFs responded indistinguishably from FLIP
-/+ MEFs,
and therefore either was used as a control for FLIP
-/-
MEFs. Endotoxin-free poly(I:C) was obtained from Invi-
vogen (San Diego, CA). For poly(I:C) stimulation experi-
ments, MEFs were transfected with 6 μg/ml of poly(I:C)
using lipofectamine 2000 (LF) (Invitrogen, Carlsbad,
CA) at 8 μl/ml as described [14]. LPS was obtained
f r o mS i g m a - A l d r i c h( S t .L o u i s ,M O ) .A n t i - F L I Pm o n o -
clonal (Dave-2) and anti-b-actin polyclonal antibodies
were purchased from Abcam (Cambridge, MA). Mouse
IFN-b ELISA kit and the mouse IFN-b antibody were
purchased from PBL Interferon Source (Piscataway, NJ).
The anti-caspase-8 monoclonal antibody, 1G12, was
obtained from Axxora (San Diego, CA). Sytox green
nuclear stain was purchased from Invitrogen (Carlsbad,
CA). Homogeneous caspase assay kit was purchased
from Roche Applied Sciences (Palo Alto, CA). Alexa-
488 Caspase-3 substrate was obtained from Biotium
( H a y w a r d ,C A ) .Z - I E T D - f m ka n dz - V A D - f m k ,ac a s -
pase-8 inhibitor and a broad-spectrum caspase inhibitor,
respectively, and membrane Fas ligand (mFasL) were
purchased from R&D systems (Minneapolis, MN). Gol-
giplug™,o b t a i n e df r o mB DB i o s c i e n c e s( S a nJ o s e ,C A )
was used at the recommended concentration (1 μl/10
6
cells) for 4 hours.
Immunoblotting
MEFs were grown in 6-well dishes to a density of 10
6/well
and processed using the protocol as described [13]. Anti-
FLIP antibody was used to probe the blot at a concentra-
tion of 1 μg/ml (1:1000). Afterwards, the blots were
stripped using Stripping buffer (Pierce, Rockford, IL) and
probed with anti b-actin antibody at 1:5000 dilution.
Anti-caspase-8 and anti-IFN-b antibodies were used at
1:1000 dilution.
RNA isolation and quantitative RT-PCR
Total RNA was extracted from the MEFs using the
RNeasy RNA extraction kit from Qiagen (Germantown,
MD) and cDNA synthesis was performed using 1 ug of
total RNA according to the manufacturer’s instructions
(Invitrogen). Fluorescent quantitative real time PCR was
performed using the Applied Biosystems HT 7900 system
with the ABI Sybr Green PCR mastermix, and the data
were analyzed using the ABI’s SDS 2.1 software (Applied
Biosystems, Foster City, CA). Mouse RT-PCR primer
sequences are as follows: IFN-b forward primer-CCCT
ATGGAGATGACGGAGA and reverse primer-ACCCAG
TGCTGGAGAAATTG, IFN-a4-forward primer CTGCT
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GAGAGGGCTCTCCAG, IL-6 forward primer-AGTTGC
CTTCTTGGGACTGA and reverse primer-TCCAC-
GATTTCCCAGAGAAC, GAPDH forward primer-GCA-
CAGTCAAGGCCGAGAAT and reverse primer-5’-GCC
TTCTCCATGGTGGTGAA.
Sytox green viability assay
For apoptosis assays, MEFs were seeded at a density of
10
4 cells/well, followed by transfection with poly(I:C) at
6 μg / m li nt h ep r e s e n c eo f8μl LF per ml of culture
medium or poly(I:C) alone at 100 μg/ml or LF alone.
Membrane FasL (1 ng/ml) was used as a positive control
as it is known to cause apoptosis in FLIP
-/- MEFs [15].
Sytox green dye (5 μM) was added simultaneously along
with various treatments, and the plates were read on a
Cytofluor Series 4000 fluorescence plate reader (Persep-
tive Biosystems Inc., Framingham, MA) at 485 nm exci-
tation and 530 nm emission after 6 hour treatment. The
fluorescence on the Y-axis is representative of cells
undergoing cell death.
Homogenous caspase assay
MEFs were seeded at 10
4 cells/well, cultured overnight,
and either pretreated or not with z-IETD-fmk (100 μM)
or z-VAD-fmk (100 μM) for 30 minutes followed by
transfection with LF and poly(I:C) together, with appro-
priate controls such as poly(I:C), LF, or the caspase inhi-
bitors (data not shown); and the caspase activity was
measured using a fluorimetric caspase assay according
to the manufacturer’s instructions (Roche Applied
Sciences), as described previously [13].
Alamar Blue Viability assay
To assess viability, WT or FLIP
-/- MEFs were seeded into
96-well plates at a density of 20,000 cells/well. After 24 h
in culture, cells were subjected to various experimental
conditions and 3 h prior to the end of treatment, Alamar
Blue (10% final concentration; BIOSOURCE Interna-
tional, Inc., Camarillo, CA) was added. Fluorescence of
monolayers was assessed in a Cytofluor Series 4000 plate
reader (Perseptive Biosystems Inc., Framingham, MA) at
5 3 0n me x c i t a t i o na n d5 9 0n me m i s s i o n ,a n dr e l a t i v e
viability was expressed in arbitrary fluorescence units.
Trypan Blue dye exclusion Viability assay
To assess viability, FLIP
-/- MEFs were seeded into
96-well plates at a density of 20,000 cells/well. After
24 h in culture, cells were subjected to various experi-
mental conditions for 14 hours. Cells were washed two
times with PBS, trypsinized, spun to collect, resuspended
in 200 μl PBS, diluted 1:1 with Trypan blue solution, the
cells that excluded the dye were counted on the hemo-
cytometer, and the % of viable cells reported.
Statistical analysis
Statistical analysis was performed using the Graphpad
statistical package (GraphPad Software Inc., La Jolla,
CA). Data are expressed as mean ± SEM, and values of
p < 0.05 were considered statistically significant. A two-
tailed t test was used to compare mean values for two-
g r o u pc o m p a r i s o n s .T oc o m pare responses between
multiple groups, data were analyzed either by one-way
ANOVA with Bonferroni’s Multiple Comparison post
hoc test or by two-way analysis of variance and the Bon-
ferroni-post-hoc comparison test was used to compare
mean values between groups.
Results
FLIP protects MEFs against cytoplasmic poly(I:C)-induced
cell death
Wild-type and FLIP
-/- MEFs were assessed for their sen-
sitivity to LF/poly(I:C) using the Sytox green assay, which
is a fluorescent nuclear dye that enters only membrane
compromised cells. As reported by others [14,16], we
f o u n dt h a tM E F sr e s p o n d e dt op o l y ( I : C )w h e ni tw a s
transfected intracellularly by LF, but not to poly(I:C)
alone (Figures 1A, B). The reason for this could be the
undetectable endogenous levels of surface TLR3 in MEFs
as measured by flow cytometry [data not shown and 16].
It has been previously demonstrated that TLR3 and TRIF
are not involved in MEF responses to LF/poly(I:C); rather
the intracellular sensors, RIG-I and IPS-1 mediate the
response to cytoplasmic dsRNA [16].
FLIP
-/- MEFs treated with LF/poly(I:C) showed a dose-
dependent increase in fluorescence, indicative of cell
death, as compared to poly (I:C) (data not shown), LF,
or untreated cells (Figure 1A). Compared with wild-type
MEFs at 6 hours, FLIP
-/-cells were markedly more sensi-
tive to cell death in response to LF/poly(I:C). Also,
mFasL caused massive cell death in FLIP
-/-MEFs as
compared to wild type MEFs, consistent with previous
studies [15]. Previous studies have shown that intracellu-
lar dsRNA induces apoptosis by a FADD and caspase-8-
dependent mechanism [17,18]. We therefore assessed
caspase activation in LF/poly(I:C)-treated MEFs using a
homogeneous caspase activity assay. Cells were pre-
treated with the broad-specificity caspase inhibitor
zVAD-fmk or the caspase-8-selective inhibitor, z-IETD-
fmk. LF/poly(I:C) and mFasL induced a marked increase
in caspase activity in FLIP
-/-cells compared to wild-type
cells (Figure 1B), which was attenuated by pretreatment
with zVAD-fmk or zIETD-fmk (Figure 1B). Further, we
used the Alamar Blue metabolic assay to assess viability.
Compared to WT MEFs, FLIP-/- MEFs showed a signif-
icant decline in fluorescence, indicative of cell death, in
response to cytoplasmic dsRNA (Additional file 1). We
also assessed cell viability by a trypan blue exclusion via-
bility assay. As expected, treatment with LF/poly(I:C)
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VAD-fmk (Additional file 2). Caspase activation was also
detected by flow cytometric analysis using Nucview™A-
lexa-488-caspase 3 fluorogenic substrate, which detects
caspase-3 activity in live cells. Again, FLIP
-/- cells
showed increased fluorescence compared to wild-type
MEFs, indicative of caspase-3 activity, and this was par-
tially reversed by pretreatment with z-IETD-fmk (data
not shown). These results suggest that FLIP protects
MEFs from cytoplasmic dsRNA-induced caspase
activation.
FLIP suppresses LF/poly(I:C)-induced NF-B- and IRF3-
mediated gene expression in MEFs
Using wild type and FLIP-/- MEFs, we examined gene
expression in response to intracellular dsRNA. The
expression of ifna4 is regulated by IRF3, il-6 by NF-B,
and ifnb by the cooperative activation of both transcrip-
tion factors [19-21]. Wild-type cells showed increased
expression of il-6, ifna4,a n difnb genes after 4 hrs of sti-
mulation with LF/poly(I:C) as compared to untreated
cells. Notably, compared to wild type MEFs, FLIP
-/-MEFs
showed markedly increased induction for all 3 genes
(Figure 2A).Untreated cells or cells treated with LF or
poly(I:C) alone did not induce significant gene expression
in either wild-type or FLIP
-/-MEFs (data not shown).
In order to confirm results obtained by mRNA expres-
sion, IFN-b protein was assessed by ELISA. In response
to LF/poly(I:C), FLIP
-/-MEFs generated more IFN-b
than wild-type cells or FLIP
-/-cells reconstituted with
FLIP (data not shown), and this overproduction was
unaffected when FLIP
-/-cells were pretreated with the
caspase 8 inhibitor to prevent cell death during the
incubation (data not shown). This result suggests that
Figure 1. 
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Figure 1 FLIP
-/- MEFs are more susceptible to cytoplasmic poly(I:C)-induced killing. (A) WT (open bars) and FLIP
-/- (closed bars) MEFs were
untreated, transfected with LF (8 μg/ml) + poly(I:C) (1.5, 3, 6 μg/ml) or treated with mFasL (1 ng/ml) for 6 hrs and assayed for viability using the Sytox
green dye. Values represent the means of 3 wells in a single experiment. Similar results were obtained in two independent experiments. *p < 0.05
compared to WT (B) WT (open bars) and FLIP
-/- (closed bars) MEFs were either untreated or pretreated with z-IETD-fmk or z-VAD-fmk (100 μM) for 1
hour and then treated with LF/poly(I:C) or mFasL (1 ng/ml) for 6 hrs. Viability was determined by homogeneous caspase assay. Values represent the
means of 3 wells in a single experiment. *p < 0.05 compared to WT. Similar results were obtained in two independent experiments.
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of IFN-b in response to cytoplasmic dsRNA (vide infra).
We also examined levels of intracellular IFN-b in
MEFs treated with Golgiplug™ (brefeldin A), which pre-
vents cytokine secretion [22]. Compared to WT MEFs,
FLIP
-/- cells showed increased intracellular levels of
IFN-b in response to LF/poly(I:C) (Figure 2B).
Reconstitution of FLIP reverses the enhanced NF-KB and
IRF3 activation in FLIP
-/- MEFs in response to cytoplasmic
dsRNA
In order to confirm that the enhanced NF-B- and
IRF3-mediated gene expression noted above (Figure 2A,
B) was due to the absence of FLIP, we tested FLIP
-/-
MEFs, which had been stably transfected with a GFP
vector alone or vector harboring full-length FLIP [13].
Western blot analysis confirmed the over-expression of
FLIP in FLIP
-/-MEFs that were reconstituted with FLIP
(Figure 3A). Upon stimulation with LF/poly(I:C), FLIP
-/-
MEFs reconstituted with GFP vector alone showed
increased expression of il-6, ifna4,a n difnb genes com-
pared to cells reconstituted with FLIP (Figure 3B). Thus,
the reconstitution of FLIP in the FLIP
-/- cells reversed
the enhancement of NF-B -a n dI R F 3 - i n d u c e dg e n e
activation in response to cytoplasmic dsRNA.
Caspase-8 catalytic activity is not required for intracellular
dsRNA-mediated signaling
Takahashi and others [8] reported that caspase-8 pro-
cessing occurs in response to dsRNA stimulation and
that the caspase-8-deficient MEFs have impaired NF-
B-mediated gene expression but intact IRF3 signaling.
Based on these observations, we investigated whether
caspase-8 catalytic activity was required for NF-Ba n d
Figure 2. 
A.  
* 
* 
* 
B.  
        WT MEF       FLIP -/- MEF 
  1         2         3        4 
mIFN- 
(~20kDa) 
POLY(I:C)        -        +        -         +   
 -actin 
Figure 2 FLIP
-/- MEFs show enhanced NF-B- and IRF3-induced gene expression in response to cytoplasmic dsRNA. A. Total RNA was isolated
from WT and FLIP
-/- MEFs 4 hours after they were either left untreated or treated with LF (8 μg/ml) + poly(I:C) (6 μg/ml). RNA was isolated, reverse-
transcribed, and mRNA levels of il6, ifnb or ifna4 were quantified by RT-PCR with respect to gadph as an endogenous control. The data are
representative of three experiments with similar findings. *p < 0.05 compared to WT. B. Wild type and FLIP
-/- MEFs were either left untreated (lanes 1
and 3 respectively) or treated with LF/poly(I:C) (lanes 2 and 4 respectively) for 4 hrs. They were all treated with Brefeldin A (Golgiplug™) for 4 hours.
Cell lysates were prepared and analyzed by immunoblot for IFN-b. The data are representative of two experiments with similar results.
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mic dsRNA in FLIP-/-MEFs. We first confirmed that
caspase-8 was activated in the FLIP
-/-cells by immuno-
blot analysis of procaspase-8 proteolytic cleavage in
response to LF/poly(I:C). As shown in Figure 4A, FLIP
-/-
cells showed increased caspase-8 processing as indicated
by the appearance of lower molecular weight cleavage
products upon treatment with LF/poly(I:C) compared to
untreated FLIP
-/-cells. This processing was reduced by
z-VAD-fmk pretreatment. We also confirmed that treat-
ment with mFasL led to caspase-8 cleavage, which was
reduced by pretreatment with z-VAD-fmk (Additional
file 3). Having demonstrated that procaspase-8 is pro-
cessed in FLIP
-/-cells treated with LF/poly(I:C), similar
to mFasL, and that processing was attenuated with a
caspase-selective inhibitor, we next examined the effect
of inhibition of caspase-8 catalytic activity on NF-B-
and IRF3-induced gene expression. FLIP
-/-cells were pre-
treated with the z-VAD-fmk, for 1 hour followed by
incubation with LF/poly(I:C) for 4 hours. Cells were
analyzed for the expression of NF-Ba n dI R F 3t a r g e t
genes by RT-PCR. We found that z-VAD-fmk did not
significantly affect the level of induction of il-6, ifnb or
ifna4 (Figure 4B), suggesting that caspase-8 catalytic
activity was not required NF-B- and IRF3-induced
gene expression.
Discussion
There is compelling evidence that the death receptor sig-
naling proteins TRADD, FADD, and caspase-8 are
B.  A. 
Figure 3. 
FLIP(55kDa) 
 -actin 
     1          2          3 
* 
* 
* 
Figure 3 Reconstitution of FLIP reverses the enhanced NF-KB and IRF3 gene expression in FLIP
-/- cells in response to cytoplasmic poly
(I:C). (A). FLIP
+/- (lane1), FLIP
-/- (lane 2), and reconstituted FLIP
-/- (lane 3) MEFs were subjected to immunoblot analysis with anti-FLIP antibody. (B).
FLIP
-/- MEFs stably transfected with GFP vector alone or with a vector carrying FLIP-GFP were left untreated, serving as untreated control, or
treated with LF/poly(I:C) for 4 hrs and analyzed by RT-PCR for expression of il-6, ifnb or ifna4 relative to gapdh. *p < 0.05, compared to FLIP-/-
MEFs carrying GFP vector. The data are representative of three experiments with similar results.
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mic dsRNA. Michallet et al showed that TRADD is an
essential component of the RIG-like helicase antiviral
pathway [9]. Their studies showed that TRADD, a crucial
adaptor of the TNFRI, was recruited by IPS-1 and regu-
lated complex formation with TRAF3/TANK and FADD/
RIP1, leading to the activation of IRF3 and NF-B. Bala-
chandran et al [14] and Takahashi et al [8] showed that
FADD is required for both IRF3- and NF-B-mediated
activation in response to poly(I:C). Kawai et al [7] further
demonstrated that FADD and RIP1 interact with IPS-1.
We now show that the caspase-8 homologue FLIP is a
negative regulator of cytoplasmic dsRNA-induced activa-
tion of IRF3 and NF-B. FLIP is homologous in struc-
ture to caspase-8, but is catalytically inactive due to
critical mutations in the catalytic domain [13]. FLIP
associates with FADD by homophilic interaction of the
death effector domains (DED) contained within each
A.  B. 
Figure 4. 
Caspase-8  
p55 
p43/41 
1         2          3 
GAP 
C 
55kDa    
72kDa    
M    
n.s. 
Figure 4 Caspase-8 proteolytic activity is not required for cytoplasmic dsRNA-induced signaling. (A). FLIP
-/- MEFs were left untreated (lane
1), or treated with LF/poly(I:C) for 2 hours (lane 2), or pretreated for 1 hr with z-VAD-fmk (100 μM) followed by treatment with LF/poly(I:C) for 2
hours (lane 3). The cell lysates were then analyzed for procaspase-8 processing by immunoblot. (B). FLIP
-/- MEFs were either left untreated or
pretreated for 1 hr with z-VAD-fmk (100 μM) followed by LF/poly(I:C). After 4 hours the cells were analyzed by RT-PCR for expression of il-6, ifnb
or ifna4 relative to gapdh. The data are representative of three experiments with similar findings.
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the absence of FLIP there is increased availability of
FADD for formation of the RLH signaling module of
TRADD-FADD-RIP1 [9], thus accounting for the
increased activation NF-Ba n dI R F 3i nF L I P
-/- cells.
Additionally, FLIP, via its DED, interacts with NF-kap-
paB-inducing kinase (NIK) and IkappaB kinase (IKK)
[13]. Since these molecules are involved in the dsRNA
induction of NF-B activation [23], FLIP binding and/or
sequestering of NIK and IKK could hinder their ability
to promote NF-B signaling.
Our studies also show that caspase activity may not be
required for activation of IRF3 and NF-B in response to
intracellular dsRNA. Using z-VAD-fmk at doses (100 μM)
that abrogated all intracellular caspase activity induced by
LF/poly(I:C), we found no effect of caspase blockade on
LF/poly(I:C)-induced IRF3-and NF-B-mediated gene
expression. These results are in agreement with Balachan-
dran et al [14] who showed that activation of an IFN-b
promoter by LF/poly(I:C) was similar in caspase-8
-/-and
WT MEFs. Furthermore, in their studies, although
z-VAD-fmk (100 μM) prevented apoptosis induced by a
Fas agonist antibody, the caspase inhibitor did not impair
LF/poly(I:C)-induced IFN-a production [14]. Takahashi
et al [8] showed that LF/poly(I:C)-induced IRF3 activation
was unaffected and early NF-B activation was reduced in
caspase-8
-/- MEFs. Most recently, Rajput et al,r e p o r t e d
that there was enhanced activation of IRF3 by poly(I:C) in
caspase-8
-/- MEFs and that RIG-I-mediated activation of
IRF-3 induced by intracellular dsRNA was negatively regu-
lated by a caspase-8-dependent cleavage of RIP1 protein
[24]. They further reported that siRNA-mediated knock-
down of caspase-8 had no effect on NF-B activation by
Sendai virus infection. Together, it appears that caspase-8
activity may not be required for IRF3 or NF-B activation
induced by cytoplasmic dsRNA.
Conclusions
In conclusion, we demonstrate a pivotal role for FLIP in
protecting cells from the apoptosis and attenuating cyto-
kine responses induced by cytoplasmic dsRNA. We have
identified FLIP as a crucial molecule that regulates the
response in MEFs: FLIP suppresses both inflammatory
and apoptotic pathways. Strategies to increase expression
of FLIP would be expected to dampen the excessive
inflammation as well as apoptosis.
Additional material
Additional file 1: Viability of WT and FLIP
-/- MEFs as assessed by
Alamar Blue assay is reduced by treatment with LF/poly(I:C).
Metabolic activity of WT and FLIP
-/- MEFs was assessed by Alamar Blue
assay after 14 hours of treatment with medium alone, LF (8 μl), poly(I:C)
(6 μg/ml), or LF/poly(I:C). Values represent means (± S.E.) with metabolic
activity reported in arbitrary fluorescent units. p < 0.05, *, LF/poly(I:C)
significantly reduced viability compared to untreated FLIP-/- MEFs.
Additional file 2: Viability of FLIP
-/- MEFs as assessed by Trypan
Blue dye exclusion is reduced by treatment with LF/poly(I:C).
Percent of FLIP
-/- MEF cells excluding Trypan Blue dye was assessed after
14 hours treatment with medium alone, dimethyl sulfoxide (DMSO), LF (8
μl), poly(I:C) (6 μg/ml), or LF/poly(I:C) with or without z-VAD-fmk (10 or
100 μM). p < 0.05, *, LF/poly(I:C) significantly reduced viability compared
to untreated cells, #, p < 0.05, 100 μM z-VAD-fmk significantly inhibits LF/
poly(I:C) induced cell death.
Additional file 3: Treatment with mFasL induces processing of
caspase-8 in FLIP
-/- MEFs. FLIP
-/- MEFs were left untreated (lane 1), or
treated with mFasL for 6 hours (lane 2), or pretreated for 1 hr with z-
VAD-fmk (100 μM) followed by treatment with mFasL for 6 hours (lane
3). The cell lysates were then analyzed for procaspase-8 processing by
immunoblot.
Acknowledgements
We would like to acknowledge the financial support from NIH grant
GM071398 (JH).
Author details
1Division of Cardiology, Department of Medicine, Box 358055, 815 Mercer
Street, University of Washington, Seattle, WA 98109, USA.
2Diabetes and
Obesity Center of Excellence, Department of Medicine, Box 358055, 815
Mercer Street, University of Washington, Seattle, WA 98109, USA.
3Division of
Hematology, University of Washington, Harborview Medical Center, Box
359756, 325 Ninth Avenue, Seattle, WA 98104, USA.
Authors’ contributions
All authors have read and approved the manuscript.
Conceived and designed the experiments: PH, JH. Performed the
experiments: PH, JT, KJ. Analyzed the data: PH, JH. Wrote the paper: PH, JH.
Competing interests
The authors declare that they have no competing interests.
Received: 30 October 2010 Accepted: 2 June 2011
Published: 2 June 2011
References
1. Kawai T, Akira S: Toll-like receptor and RIG-I-like receptor signaling. Ann N
Y Acad Sci 2008, , 1143: 1-20.
2. Takeda K, Akira S: Toll-like receptors in innate immunity. Int Immunol
2005, 17:1-14.
3. Meylan E, Tschopp J: Toll-like receptors and RNA helicases: two parallel
ways to trigger antiviral responses. Mol Cell 2006, 22:561-569.
4. Schlee M, Roth A, Hornung V, Hagmann CA, Wimmenauer V, Barchet W,
Coch C, Janke M, Mihailovic A, Wardle G, Juranek S, Kato H, Kawai T,
Poeck H, Fitzgerald KA, Takeuchi O, Akira S, Tuschl T, Latz E, Ludwig J,
Hartmann G: Recognition of 5’ triphosphate by RIG-I helicase requires
short blunt double-stranded RNA as contained in panhandle of
negative-strand virus. Immunity 2009, 31:25-34.
5. Kumar H, Kawai T, Akira S: Pathogen recognition by the innate immune
system. Int Rev Immunol 2011, 30:16-34.
6. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K,
Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T,
Koh CS, Reis e Sousa C, Matsuura Y, Fujita T, Akira S: Differential roles of
MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006,
441:101-5.
7. Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S:
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon
induction. Nat Immunol 2005, 6:981-988.
8. Takahashi K, Kawai T, Kumar H, Sato S, Yonehara S, Akira S: Roles of
caspase-8 and caspase-10 in innate immune responses to double-
stranded RNA. J Immunol 2006, 176:4520-4524.
Handa et al. Cell Communication and Signaling 2011, 9:16
http://www.biosignaling.com/content/9/1/16
Page 8 of 99. Michallet MC, Meylan E, Ermolaeva MA, Vazquez J, Rebsamen M, Curran J,
Poeck H, Bscheider M, Hartmann G, König M, Kalinke U, Pasparakis M,
Tschopp J: TRADD protein is an essential component of the RIG-like
helicase antiviral pathway. Immunity 2008, 28:651-61.
10. Krueger A, Baumann S, Krammer PH, Kirchhoff S: FLICE-inhibitory proteins:
regulators of death receptor-mediated apoptosis. Mol Cell Biol 2001,
21:8247-8254.
11. Hughes MA, Harper N, Butterworth M, Cain K, Cohen GM, MacFarlane M:
Reconstitution of the death-inducing signaling complex reveals a
substrate switch that determines CD95-mediated death or survival. Mol
Cell 2009, 35:265-79.
12. Kreuz S, Siegmund D, Rumpf JJ, Samel D, Leverkus M, Janssen O, Häcker G,
Dittrich-Breiholz O, Kracht M, Scheurich P, Wajant H: NFkappaB activation
by Fas is mediated through FADD, caspase-8, and RIP and is inhibited
by FLIP. J Cell Biol 2004, 166:369-80.
13. Bannerman DD, Eiting KT, Winn RK, Harlan JM: FLICE-like inhibitory protein
(FLIP) protects against apoptosis and suppresses NF-kappaB activation
induced by bacterial lipopolysaccharide. Am J Pathol 2004, 165:1423-1431.
14. Balachandran S, Thomas E, Barber GN: A FADD-dependent innate immune
mechanism in mammalian cells. Nature 2004, 432:401-405.
15. Yeh WC, Itie A, Elia AJ, Ng M, Shu HB, Wakeham A, Mirtsos C, Suzuki N,
Bonnard M, Goeddel DV, Mak TW: Requirement for Casper (c-FLIP) in
regulation of death receptor-induced apoptosis and embryonic
development. Immunity 2000, 12:633-42.
16. Balachandran S, Venkataraman T, Fisher PB, Barber GN: Fas-associated
death domain-containing protein-mediated antiviral innate immune
signaling involves the regulation of Irf7. J Immunol 2007, 178:2429-39.
17. Balachandran S, Kim CN, Yeh WC, Mak TW, Bhalla K, Barber GN: Activation
of the dsRNA-dependent protein kinase, PKR, induces apoptosis through
FADD-mediated death signaling. EMBO J 1998, 17:6888-902.
18. Iordanov MS, Kirsch JD, Ryabinina OP, Wong J, Spitz PN, Korcheva VB,
Thorburn A, Magun BE: Recruitment of TRADD, FADD, and caspase 8 to
double-stranded RNA-triggered death inducing signaling complexes
(dsRNA-DISCs). Apoptosis 2005, 10:167-76.
19. Bonjardim CA: Interferons (IFNs) are key cytokines in both innate and
adaptive antiviral immune responses and viruses counteract IFN action.
Microbes Infect 2005, 7:569-78.
20. Andersen J, VanScoy S, Cheng TF, Gomez D, Reich NC: IRF-3-dependent
and augmented target genes during viral infection. Genes Immun 2008,
9:168-75.
21. Miettinen M, Sareneva T, Julkunen I, Matikainen S: IFNs activate toll-like
receptor gene expression in viral infections. Genes Immun 2001, 2:349-55.
22. Reimer T, Brcic M, Schweizer M, Jungi TW: Poly(I:C) and LPS induce
distinct IRF3 and NF-kappaB signaling during type-I IFN and TNF
responses in human macrophages. J Leukoc Biol 2008, 83:1249-57.
23. Zamanian-Daryoush M, Mogensen TH, DiDonato JA, Williams BR: NF-
kappaB activation by double-stranded-RNA-activated protein kinase
(PKR) is mediated through NF-kappaB-inducing kinase and IkappaB
kinase. Mol Cell Biol 2000, 20(4):1278-90.
24. Rajput A, Kovalenko A, Bogdanov K, Yang SH, Kang TB, Kim JC, Du J,
Wallach D: RIG-I RNA Helicase Activation of IRF3 Transcription Factor Is
Negatively Regulated by Caspase-8-Mediated Cleavage of the RIP1
Protein. Immunity 2011, 34:340-51.
doi:10.1186/1478-811X-9-16
Cite this article as: Handa et al.: FLIP (Flice-like inhibitory protein)
suppresses cytoplasmic double-stranded-RNA-induced apoptosis and
NF-B and IRF3-mediated signaling. Cell Communication and Signaling
2011 9:16. Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Handa et al. Cell Communication and Signaling 2011, 9:16
http://www.biosignaling.com/content/9/1/16
Page 9 of 9